Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label mass balance study of [14C]-etripamil nasal spray in healthy male subjects
NL-OMON50057Completed
- Sponsor
- Milestone Pharmaceuticals
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of etripamil in paroxysmal supraventricular tachycardia (PSVT), sponsored by Milestone Pharmaceuticals. Primary endpoints: Whole blood total radioactivity Cmax, Whole blood total radioactivity tmax and 3 more. Started Oct 2020; status: completed.
02
Drugs
etripamil
03
Conditions
paroxysmal supraventricular tachycardia (PSVT)
Beyond the preview
Go deeper on NL-OMON50057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50057.